Human gene therapy - JoVE Visualize

Showing results (2071-2080 of 4,124) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|June 18, 2002

Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapyGyula Acsadi, Roumen A Anguelov, Huibin Yang, et al.

Human Gene Therapy|June 18, 2002

Efficient oncoretroviral transduction of extended long-term culture-initiating cells and NOD/SCID repopulating cells: enhanced reconstitution with gene-marked cells through an ex vivo expansion approachHelga Björgvinsdóttir, David Bryder, Ewa Sitnicka, et al.

Human Gene Therapy|July 23, 2002

A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparationsFlorian Kreppel, Volker Biermann, Stefan Kochanek, et al.

Human Gene Therapy|July 23, 2002

The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitopeMelanie Olive, Laurence Eisenlohr, Neal Flomenberg, et al.

Human Gene Therapy|July 23, 2002

Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2Joon Yung Lee, Hairong Peng, Arvydas Usas, et al.

Human Gene Therapy|July 23, 2002

Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastasesRichard J Wong, John K Joe, Se-Heon Kim, et al.

Human Gene Therapy|August 7, 2002

Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapyRoland W Herzog, Paul A Fields, Valder R Arruda, et al.

Human Gene Therapy|August 7, 2002

Development of second- and third-generation bovine immunodeficiency virus-based gene transfer systemsMeghan Matukonis, Mengtao Li, Rene P Molina, et al.

Human Gene Therapy|August 7, 2002

Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic delivery of an adenoviral vectorJulie L Andrews, Pamela S Shirley, William O Iverson, et al.

Human Gene Therapy|August 7, 2002

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomiesJohn A Wagner, Ilynn B Nepomuceno, Anna H Messner, et al.

Pageof 413

Showing results (2071-2080 of 4,124) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|June 18, 2002

Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapyGyula Acsadi, Roumen A Anguelov, Huibin Yang, et al.

Human Gene Therapy|June 18, 2002

Efficient oncoretroviral transduction of extended long-term culture-initiating cells and NOD/SCID repopulating cells: enhanced reconstitution with gene-marked cells through an ex vivo expansion approachHelga Björgvinsdóttir, David Bryder, Ewa Sitnicka, et al.

Human Gene Therapy|July 23, 2002

A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparationsFlorian Kreppel, Volker Biermann, Stefan Kochanek, et al.

Human Gene Therapy|July 23, 2002

The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitopeMelanie Olive, Laurence Eisenlohr, Neal Flomenberg, et al.

Human Gene Therapy|July 23, 2002

Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2Joon Yung Lee, Hairong Peng, Arvydas Usas, et al.

Human Gene Therapy|July 23, 2002

Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastasesRichard J Wong, John K Joe, Se-Heon Kim, et al.

Human Gene Therapy|August 7, 2002

Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapyRoland W Herzog, Paul A Fields, Valder R Arruda, et al.

Human Gene Therapy|August 7, 2002

Development of second- and third-generation bovine immunodeficiency virus-based gene transfer systemsMeghan Matukonis, Mengtao Li, Rene P Molina, et al.

Human Gene Therapy|August 7, 2002

Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic delivery of an adenoviral vectorJulie L Andrews, Pamela S Shirley, William O Iverson, et al.

Human Gene Therapy|August 7, 2002

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomiesJohn A Wagner, Ilynn B Nepomuceno, Anna H Messner, et al.

Pageof 413